Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Krishna Institute of Medical Sciences Limited ( (IN:KIMS) ) has provided an announcement.
Krishna Institute of Medical Sciences Limited has entered into a long-term leave and license agreement with Andhra Mahila Sabha to lease approximately 1.168 acres of land in Raja Annamalai Puram, Chennai, for the establishment of a new super-speciality hospital. The planned facility will add around 300 beds to KIMS’s network within the next 36 months, requiring an estimated investment of Rs 300 crore funded through a mix of bank loans and internal accruals. This expansion marks KIMS’s first entry into Tamil Nadu, a strategic move aimed at enhancing its geographic presence, improving operational performance, and supporting sustainable long-term financial returns, even as the company currently operates at about 51% occupancy across its existing capacity.
More about Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited (KIMS) is a healthcare services provider operating a network of hospitals, with an overall capacity of more than 8,800 beds as of September 30, 2025. The company focuses on multi- and super-speciality tertiary care, and is expanding its footprint across India to serve a wider patient base in key urban markets.
Average Trading Volume: 49,406
Technical Sentiment Signal: Buy
Current Market Cap: 255.9B INR
Learn more about KIMS stock on TipRanks’ Stock Analysis page.